General Medicine & Surgery: Medical Student Revision Guide
General Medicine & Surgery: Medical Student Revision Guide
Endocrinology
Gastroenterology
General Hepato-pancreato-biliary
Medicine
Haematology
Renal
medical student revision guide Respiratory
Surgical principles
Emergency presentations
We’ve worked really hard with the authors to ensure that everything in the book is correct. However, errors
and ambiguities can still slip through in books as complex as this. If you spot anything you think might be
wrong, please email us and we will look into it straight away. If an error has occurred, we will correct it for
future printings and post a note about it on our website so that other readers of the book are alerted to this.
Endocrinology
Gastroenterology
General Hepato-pancreato-biliary
Medicine
Haematology
Renal
medical student revision guide Respiratory
Surgical principles
Critical illness
Emergency presentations
Rheumatology
All rights reserved. No part of this book may be reproduced or transmitted, in any form
or by any means, without permission.
A CIP catalogue record for this book is available from the British Library.
ISBN 9781914961182
www.scionpublishing.com
Readers are reminded that medicine is a constantly evolving science and while the
authors and publishers have ensured that all dosages, applications and practices are
based on current indications, there may be specific practices which differ between
communities. You should always follow the guidelines laid down by the manufacturers
of specific products and the relevant authorities in the country in which you are
practising.
Although every effort has been made to ensure that all owners of copyright material
have been acknowledged in this publication, we would be pleased to acknowledge in
subsequent reprints or editions any omissions brought to our attention.
Registered names, trademarks, etc. used in this book, even when not marked as such, are
not to be considered unprotected by law.
Printed in the UK
Foreword
A book such as this takes time, effort and dedication from all the contributors who do this alongside their already busy clinical work.
It is heartening to see this commitment to supporting the education and advancement of the next generation of doctors and allied
health professionals.
I like the unique style which is based on Dr Richardson’s personal notes whilst a medical student. It is simple, engaging and easy to
read, whatever your learning preferences (I particularly like the colour coding!) It also covers topics comprehensively, making it not
only a great aide-memoire but also a very useful everyday book on the ward. The judicious use of references (e.g. NICE guidelines and
BMJ Best Practice) also enables readers to look into subjects in depth if needed, without affecting the flow of the text.
Once again, I commend the authors on their remarkable efforts and wish everyone who picks up this book well in their careers.
Preface
I remember it well. Countless evenings sat at my desk, desperately trying to work out what I needed to know, and how I was going
to know it. Hours spent trudging through textbooks, soaking up line after line of information, only to be left certain that after a week
on my new placement, it would all be forgotten. Medical school is tough. The vast volume of knowledge that must be acquired and
retained, to achieve the standards expected of a safe and successful doctor, is a daunting task. But as you will find at every stage in
your medical career, help is always available if you know where to look. For you, I hope this book can be your help. I present it as
your trusted companion, a loyal friend that will stand by your side through good times and bad, something to turn to when you need
guidance, reassurance, or simply just a place to start!
There is no end of resources available for medical students, all designed to make the journey from student to doctor that little bit
easier. For me, I found this wealth of information to be just as much of a curse as it was a blessing. Not only was I faced with the
overwhelming task of learning it all, but I first had to find and dissect the parts that were relevant to me. Wouldn’t it be easier if
everything I needed to know was in the same place? The simple answer – yes. And that is how I started to write this book.
My first goal when creating the Medical Student Revision Guides was to bring together all the key topics needed for medical school
exams and life as a junior doctor in one readily available place. I did this through summarising a variety of recognised resources,
including textbooks, articles and clinical guidelines. This has been supplemented by the expert knowledge of specialists in each
field, who have reviewed each chapter to ensure it is accurate and reflects the most up-to-date guidance.
My second goal was to do everything I could to help you remember this information. I appreciate everyone is unique in the way
they learn, but with most of us relying on vision as our dominant sense, it seemed illogical not to utilise its power. As such, I have
specifically designed this book with an extensive use of colour, diagrams and summary tables, to create a resource that is visually
striking and a refreshing change from your current textbooks. The informal ‘notes-style’ layout and dedicated column that allows for
your own annotations on each page, are features that I hope make the content feel more accessible and easier to engage with.
It is my sincere hope that you find this book useful, whether it be as your comprehensive revision resource, or a quick reminder of a
condition that you come across on the ward. I am forever grateful for any feedback that can help me to better help you, so please
do leave a review with your honest thoughts.
I wish you luck with your exams, and all the best for your future careers.
Rebecca Richardson
Disclaimer
It is important to note that this book is designed as a revision tool and aide-memoire. It is not intended to give an in-depth understanding of each condition, but
rather to focus on the key points that often appear in undergraduate exams. It should not be solely relied upon in clinical situations; please always check the most
current and local guidelines before implementing management or administering any treatment.
Every attempt has been made to ensure that the most up-to-date information has been included at the time of writing this book. However, due to the continuously
evolving nature of the medical profession, and with variations in clinical practice between hospital Trusts, this cannot be guaranteed. It is therefore advised that
you correlate these notes to other resources, and supplement them with your own clinical encounters, to ensure a complete learning experience. Readers should
also ensure that they learn all elements of their own medical school curriculum, regardless of whether they are covered in this book.
Acknowledgements
I must firstly say a huge thank you to the team at Scion Publishing for making this book a reality. A special mention to Jonathan and
Clare, for your tireless work overcoming layout issues and design problems, to ensure the end product was everything I had hoped it
would be.
Secondly, I would like to thank my co-author, Ricky. Your advice and guidance have been invaluable in this process. Your wealth of
experience in the field of medical education has undoubtedly benefited the book and its readers, and remains an inspiration for my
future work.
My thanks are extended to all those who have contributed time and expertise as a chapter reviewer. I will be eternally grateful
that you could see the potential in my work in its early stages and gave up your own time to help me achieve it. The abundance of
knowledge and experience you have brought is priceless and will underpin the learning of many future doctors.
Finally, to my loved ones. To Mum and Dad, for the years of selflessness and sacrifice that allowed me the opportunities to achieve all
that I have today. To my brother, Chris, whose artistic talent never fails to amaze me, and has inspired the covers and diagrams of both
my books. To Nana, Gran, Grandad and Margaret, for the timeless wisdom and unconditional love that only grandparents can provide.
And to Martin, for your endless patience, support and encouragement in all that I do.
Thank you.
Peer reviewers
Section Peer reviewer
Cardiology Dr Manish Gandhi
Consultant Cardiologist, Royal Devon University Healthcare NHS Foundation Trust
Endocrinology Dr David Hughes
Consultant in Diabetes, Endocrinology & Bariatric Medicine, University Hospitals of Derby and Burton NHS Trust
Gastroenterology Dr J H Williams
Hepatobiliary Consultant Gastroenterologist, University Hospitals of Derby and Burton NHS Foundation Trust
Haematology Dr M Bishton
Clinical Associate Professor, University of Nottingham, School of Translational Sciences
Honorary Consultant Haematologist Nottinghamshire University Hospitals NHS Trust
National Cancer Registration and Analysis Service (NCRAS) lead for Haemato-oncology NHS-Digital
Neurology Dr S L Toh
Consultant Neurologist, University Hospitals of Derby and Burton NHS Foundation Trust
Dr M Kolappan
Consultant Neurologist, Neuro-ophthalmologist and Headache Specialist, University Hospitals of Derby and Burton NHS
Foundation Trust
Renal medicine Dr Nitin Kolhe
Consultant Nephrologist and Clinical Director for Specialist Medicine at University Hospitals of Derby and Burton NHS Trust
Respiratory Dr NJ Withers
Consultant in CF/Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust
General surgery Miss Ruth Parks
GI surgery General Surgery Registrar (East Midlands North), Clinical Research Fellow (University of Nottingham)
General abbreviations
Each chapter begins with a set of abbreviations specific for that chapter.
2ww – 2 week wait eGFR – Estimated GFR PCR – Polymerase chain reaction
a. – Arterial ENT – Ear, nose and throat PE – Pulmonary embolism
ABCDE – Airways, Breathing, Circulation, EPO – Erythropoeitin PET – Positron emission tomography
Disability, Exposure ESR – Erythrocyte sedimentation rate PHx – Past history
ABG – Arterial blood gas FBC – Full blood count PNS – Peripheral nervous system
ABX – Antibiotics FHx – Family history PO – (per ora) Orally
AXR – Abdominal X-ray G&S – Group & save PR – Per rectum
BB – Beta-blocker GA – General anaesthetic PRN – Pro re nata (as required)
BD – Twice a day GCS – Glasgow Coma Score/Scale pulm. – Pulmonary
BG – Blood glucose GFR – Glomerular filtration rate QDS – Four times a day
BMI – Body mass index GI – Gastrointestinal RA – Rheumatoid arthritis
BP – Blood pressure GP – General practitioner RBC – Red blood cell
ca – Cancer h – Hour RFT – Renal function test
Ca – Calcium Hb – Haemoglobin RHS – Right-hand side
CBT – Cognitive behavioural therapy HF – Heart failure r/o – Risk of
CCB – Calcium channel blocker HIV – Human immunodeficiency virus R/V – Review
CCF – Congestive cardiac failure HR – Heart rate re – Regarding
CF – Cystic fibrosis HTN – Hypertension RF – Risk factor
CHF – Chronic heart failure ICP – Intracranial pressure RR – Respiration rate
CI – Contraindication Ig – Immunoglobulin s – Second
CK – Creatine kinase IHD – Ischaemic heart disease SALT – Speech and language therapy
CKD – Chronic kidney disease IM – Intramuscular SBP – Systolic blood pressure
CMV – Cytomegalovirus inc. – Including SC – Subcutaneous
CN – Cranial nerve IV – Intravenous SD – Standard deviation
CNS – Central nervous system IVDU – Intravenous drug user SE – Side-effect
CPAP – Continuous positive airway pressure Ix – Investigation SL – Sublingual
CPR – Cardiopulmonary resuscitation JVP – Jugular venous pressure SLE – Systemic lupus erythematosus
Cr – Creatinine LFT – Liver function test SOB – Shortness of breath
CRP – C-reactive protein LHS – Left-hand side SSRI – Selective serotonin reuptake inhibitor
CRT – Capillary refill time LMWH – Low molecular weight heparin Sx – Symptoms
CSF – Cerebrospinal fluid LOC – Loss of consciousness TB – Tuberculosis
CT – Computed tomography m – Month TCA – Tricyclic antidepressant
CV – Cardiovascular mcg – Microgram TDS – Three times a day
CVA – Cerebrovascular accident MCS – Microscopy, culture and sensitivity TFT – Thyroid function test
CVD – Cardiovascular disease MDT – Multidisciplinary team TIA – Transient ischaemic attack
CXR – Chest X-ray MI – Myocardial infarction TNM – Tumour, nodes, metastases
D&V – Diarrhoea and vomiting min – Minute Tx – Treatment
d – Day MND – Motor neurone disease U&Es – Urea & electrolytes
DBP – Diastolic blood pressure MRI – Magnetic resonance imaging USS – Ultrasound scan
DDx – Differential diagnosis Mx – Management UTI – Urinary tract infection
DM – Diabetes mellitus NBM – Nil by mouth VBG – Venous blood gas
DOAC – Direct oral anticoagulant NSAID – Non-steroidal anti-inflammatory vit – Vitamin
DRE – Digital rectal examination drug VTE – Venous thromboembolism
DVLA – Driver and Vehicle Licensing Agency N&V – Nausea & vomiting W – Week
Dx – Diagnosis OCD – Obsessive–compulsive disorder WBC – White blood cell
ECG – Electrocardiogram OD – Once a day WCC – White cell count
ECT – Electroconvulsive therapy O/E – On examination WHO – World Health Organization
EEG – Electroencephalogram OT – Occupational therapist y – Year
1. Notes column – each page is divided into a main text section, and a tinted notes column. The notes column is used to house
additional information, and to provide space for your own notes, should you wish to make any.
2. Text colour
• chapter coloured text – used to expand on a point / provide extra information
• grey text – used for less important information
• red text – used for red flags and emergency points
• blue text – used for extra points / annotations
3. Highlighting – words/phrases that have been highlighted are linked to extra information. Look for another highlight of the same
colour on the page to find this information. The below example uses green highlighting to link ‘Skin fold’ to the additional information
'Normal fold thickness'.
Management1
NSTEMI/UA STEMI
Acute Morphine + metoclopramide (5–10mg) Remember acute management as 'MONA(A)'
Oxygen (if sats <90%)
Nitrates (GTN spray)
Antiplatelets (300mg chewable aspirin + loading dose ticagrelor/clopidogrel/prasugrel)
Anticoagulant (fondaparinux 2.5mg for 72h)
1. GRACE score: assess inpatient & 6m First line: primary PCI ideally if
mortality <120min from onset (95% success)
2. DAPT score: predicts who will benefit Target 150min call → balloon time
from dual antiplatelet therapy
Second line: thrombolysis
3. Angiographic assessment
(rarely used as many contraindications)
4. Revascularisation options: PCI, CABG
Long- A 1. Lifelong Aspirin: 75mg OD
RETURN TO DRIVING:
term A 2. Continue 2nd Antiplatelet: ticagrelor/clopidogrel/prasugrel (for 1y)
Angina: if Sx controlled
BB 3. Lifelong Beta-Blocker: bisoprolol (HR at 60bpm)
PCI: 1w
A 4. Lifelong Atorvastatin
CABG: 4w
A 5. ACEi: ramipril
ICD: 6m
6. Treat underlying problems: HF/HTN (BP<140/90)
Rehab Optimise physical, psychological & social functioning + stabilise/slow atherosclerosis
Patient education: about risk factors for CVD
Exercise programme: gradual return
Return to work: usually after 2w (depends on job)
GRACE score parameters to predict inpatient & 6m mortality NSTEMI: dual antiplatelet therapy
1. Age Aspirin + ticagrelor/clopidogrel/prasugrel
Although GRACE score has good predictive value → consider lower dose if high bleeding risk
2. HR of mortality, it is often not used in practice.
3. SBP (HASBLED score)
4. Creatinine Local logistics determines speed of cardiac → consider stopping if going for CABG
5. Any CHF catheterisation. STEMI have primary PCI revascularisation
6. Cardiac arrest at admission immediately on arrival, NSTEMI and unstable → consider GI protection with PPI if >65y or Hx
7. ST segment changes angina have inpatient cardiac catheterisation as of GORD/PUD
8. Elevated cardiac markers soon as feasible, prior to discharge.
Complications of ACS
D Death
A Arrhythmia AF, VF, VT, bradyarrhythmias (VF = most common complication)
R Rupture Of papillary muscles / ventricular wall / septum (causes MR, VSD & LVF)
Beck’s triad:
T Tamponade Due to ventricular wall rupture = Beck’s triad
H Heart failure May be due to VSD = cardiogenic shock 1. JVP
2. BP
3. Quiet heart sounds
V Valve problem Due to papillary muscle dysfunction/rupture = new murmur
A Aneurysm of Due to weakened ventricular wall
ventricle Dressler’s syndrome:
D Dressler’s syndrome Immune-mediated pericarditis (usually 2–3w later) 1. Fever
E Emboli From thrombus forming over damaged left ventricle wall 2. Chest pain
3. Exertional dyspnoea
R Recurrence
4. Pericardial effusion
Pituitary disorders
The pituitary gland sits below the hypothalamus & optic chiasm
effects = MASSIVE PROLACTIN (>10,000) Fig. 2.4 Functions of the pituitary gland.
Hypopituitarism
Medicine
Secretory/functional adenomas
→ can produce >1 hormone
Raised TSH & T4 usually indicates poor compliance with LT4 treatment
LH-/FSH-secreting adenoma = VERY RARE
Medicine
Oesophageal cancer
→ UK prevalence: 14 in 100,000 (increasing due to RFs)
→ M:F = 2:1
Presents late & POOR PROGNOSIS4
Squamous cell (20%): upper 2/3 oesophagus
RF = smoking, alcohol, Asian, achalasia Stage 5y Survival
Adenocarcinoma (80%): lower 1/3 oesophagus 1 53%
RF = smoking, alcohol, obesity, Barrett’s oesophagus (GORD) 2 30%
3 16%
Symptoms
4 0%
• Progressive dysphagia: solids → • Retrosternal chest pain Overall 17%
liquids → saliva • Lymphadenopathy
• Weight loss & anorexia • ± cough, aspiration, hoarseness
Investigations
• OGD & biopsy – histological grading
• CT chest, abdo, pelvis – TNM staging
• Endoscopic USS – more detailed T&N staging
• PET scan – detects metabolically active mets
TNM staging
Tumour Nodes Metastases
Tis – tumour in situ N0 none M0 no mets
T1a – invades lamina propria N1 1–2 LNs M1 distant mets
T1b – invades submucosa N2 3–6 LNs
T2 – invades muscularis propria N3 7+ LNs
T3 – invades adventitia
T4 – invades adjacent tissues
Adenocarcinoma
Tis or T1a (N0, M0) Endoscopic mucosal resection/dissection (EMR/EMD)
T1b (N0, M0) or >75yrs Surgical resection or definitive chemoradiotherapy
Complications of upper GI surgery:
T2, T3, T4 (M0) Neoadjuvant chemo → surgery + adjuvant chemo
• Weight loss – need dietetic support
Squamous cell carcinoma • Dysphagia – due to strictures
T1a (N0) EMR/EMD • Reflux
All others (M0) Neoadjuvant chemo → surgery + adjuvant chemo • Delayed emptying
Any histology with mets (M1) = palliative care
1. Chemo ± radiotherapy
2. Symptom relief: stents, analgesia
SURGICAL OPTIONS:
Ivor Lewis oesophagectomy (2 stage → open or keyhole) Oesophagus
Part removed Stomach
Stage 1 (abdominal): re-joined
• mobilise / free stomach from blood supply
Stage 2 (thoracic):
• mobilise & resect affected part of oesophagus
• pass ‘free’ stomach through hiatus & staple to remaining oesophagus
• pylorectomy to improve gastric emptying post-op
NB. Oesophageal surgery = high morbidity & mortality Fig. 3.2 Ivor Lewis oesophagectomy.
→ need careful pre-op assessment for suitability
4 Cancer survival by stage at diagnosis for England, 2019. ONS.
5 NICE (2018) Oesophago-gastric cancer [NG83] Medicine
Gastric cancer
→ UK prevalence*: 10 in 100,000 → 5th most common cancer worldwide6
*prevalence is increasing globally due to increased → M:F = 3:1 → Peak age: 50–70y
prevalence of modifiable RFs
Types
Risk factors:
→ Internal: pernicious anaemia, H. pylori, 1. Adenocarcinoma (85%)
polyps 2. Other (15%) – lymphoma, leiomyosarcoma, GISTs
→ External: smoking, high salt/nitrate
(red meat) Symptoms
→ Genetic: Japanese, HNPCC, Group A blood
• Epigastric pain / dyspepsia
• Early satiety
Presents late & POOR PROGNOSIS7 often non-specific & mimic PUD
• N&V, anorexia, weight loss
Stage 5y Survival • Dysphagia
1 65%
2 36% Investigations
3 24% • OGD & multiple ulcer edge biopsies – histological grading & location
4 0% • CT chest, abdo, pelvis – TNM staging (same as oesophageal)
Overall 20% • Endoscopic USS – more detailed T&N staging
Signs O/E
• Epigastric mass (50%)
• Virchow’s node enlargement only in late stage / metastases
• Hepatomegaly, ascites
• Jaundice, acanthosis nigricans
Management8
SURGICAL OPTIONS:
Siewert class Location Management
Gastrectomy complications: 1 1–5cm above GOJ Oesophagectomy
• Vit B12 / iron deficiency 2 <1cm above or <2cm below GOJ Oesophagectomy or total gastrectomy
• Early satiety / weight loss
• Osteoporosis/osteomalacia 3 2–5cm below GOJ Total gastrectomy
Distal Near pylorus Distal gastrectomy
Gallbladder disease
→ Gallbladder stores and concentrates bile
→ Fatty acids / amino acids in duodenum stimulate CCK release
Contents of bile:
→ CCK stimulates gallbladder contraction & bile release
• Water (97%)
Investigations • Bile salts / pigments
• Cholesterol
1. History & abdo exam + pregnancy test + urine dip
• Phospholipids
2. Bloods: FBC, CRP/ESR, LFTs, clotting (± amylase)
3. Imaging:
→ USS (shows GB/duct dilation) → ERCP (Dx & Tx but invasive) USS = FIRST-LINE imaging
→ MRCP (95% sensitive to detect stone) → CT if concerned about tumour
Complications of gallstones
most gallstones = asymptomatic, until complications
1. In gallbladder: biliary colic (cystic duct obstruction), acute cholecystitis,
perforation*, carcinoma *needs emergency cholecystectomy
2. In bile ducts: biliary colic (common duct obstruction) → ascending cholangitis Mirizzi’s syndrome:
or acute pancreatitis
Gallstone impacts in cystic duct / Hartmann’s
3. In intestine: gallstone ileus (stone erodes through gallbladder = fistula to
pouch
duodenum → intestinal obstruction) AXR shows air in biliary tree • Extrinsic compression of hepatic duct
• Obstructive jaundice without dilation of CBD
Management4
• C. perfringens
• Klebsiella
OBSTRUCTION INFLAMMATION INFECTION • E. coli
Key DDx: GORD, PUD, acute pancreatitis, Murphy’s sign: press over GB – patient has sharp pain during inspiration as
IBD, acute hepatitis, pyelonephritis peritoneum hits your hand
4 BMJ Best Practice (2021) Gallstones, acute cholecystitis, acute cholangitis
Medicine
Symptoms:
• Painless progressive jaundice Sx occur late & mimic
• Weight loss PANCREATIC CANCER
Medicine
Anaemia overview
Anaemia is defined as Hb <130g/L in men & <115g/L in women
Key questions to ask:
Investigations
DDx macrocytic anaemia: ABCDEF
• FBC – MCV (size of RBC) & MHC (Hb per RBC), reticulocytes • Alcohol & liver disease
• Iron studies – serum iron & ferritin, TIBC • B12 deficiency
• Blood film – size, shape, colour of red cells • Compensatory reticulocytosis (blood loss)
• Serum bilirubin – high in haemolysis • Drugs (cytotoxic)
• Hb HPLC or Hb electrophoresis – shows amount of each Hb type • Endocrine (hypothyroidism)
(HbS, HbA, HbF) • Folate deficiency
Types of haemoglobin
DDx normocytic anaemia: CHARMD
Fetal (HbF): 2α chains + 2γ chains → higher O2 affinity
• Chronic disease ( iron + ferritin)
Adult (HbA): 2α chains + 2β chains → lower O2 affinity
• Haemolysis
Adults normally have 2 HbA alleles (HbAA). Patients with haemoglobinopathies such as • Acute blood loss
thalassaemia or SCD have at least one abnormal allele, causing non-HbA haemoglobins • Renal anaemia (causing low EPO levels)
(e.g. HbSS, HbAS) • Marrow disorder
• Deficiencies combined (iron + B12)
Medicine
RBC aplasia
→ failure of RBC synthesis
Diagnostic results in RBC aplasia: Hb, Causes:
reticulocytes, normal BR, Coombs test –ve • Diamond–Black anaemia = rare, congenital → raised MCV ± short stature,
abnormal thumbs
• Transient erythroblastopenia = triggered by viral infection in children
• Parvovirus B19 – infects young RBCs – only causes RBC aplasia in children/
adults with inherited haemolytic anaemia
1 BNF Treatment Summary – Anaemia, Iron Deficiency
2 BNF Treatment Summary – Anaemia, Megaloblastic
Medicine
1. Facial nerve (CN VII): Corticospinal: voluntary movement of Corticobulbar: voluntary movement of face &
→ Forehead = bilateral representation contralateral body neck
→ Branch to lower face = unilateral → Originate in motor cortex → Originate in motor cortex
representation → Decussate in medullary pyramids → Terminates in brainstem
→ UMN lesion spares frontalis → Synapse with LMNs in spinal cord → Synapse with cranial nerves
2. Hypoglossal (CN XII):
→ Each half of tongue supplied by contralateral The ascending tracts
corticobulbar tract
→ Lesion causes contralateral weakness, so Dorsal column medial Spinothalamic Spinocerebellar
tongue deviates towards weak side lemniscus (DCML)
Fine touch, vibration, Pain & temperature Unconscious proprioception (ipsilateral)
proprioception (contralateral) (awareness of position & movement of
(contralateral) body parts in space without conscious
thought)
Bulbar palsy: LMN lesion causing dysarthria Pseudobulbar palsy: bilateral UMN lesion causing dysarthria = damage to medullary
= weakness of muscles supplied by CN IX, X, XII cranial nerves
→ Nasal speech / dysarthria → ‘Donald Duck’ speech (spastic dysarthria)
→ Hyporeflexia: jaw jerk & gag reflex absent → Hyperreflexia: jaw jerk & gag reflex increased
→ Tongue: weak & wasted & fasciculations → Tongue: weak & spastic
Medicine
Dermatomes Myotomes
Classification
Factors increasing risk of needing RRT
→ use to identify those most at risk of needing RRT
• Younger age • Male gender Base on 2 factors:
• Lower eGFR • Higher ACR Persistent albuminuria
1. GFR
2. Albuminuria A1 A2 A3
1. Urine dip & BP Obstructive uropathy Back-up of pressure = hydronephrosis & damage
→ Urine protein–creatinine ratio → neurogenic bladder, BPH, malignancy, stones
for nephrotic syndromes Polycystic kidney disease (PKD) → Auto dominant form presents in adults
→ Urine albumin–creatinine ratio (ACR) → Fluid-filled cysts press on nephrons = atrophy
for CKD → Sx: back pain, headaches, haematuria, HTN
2. Bloods:
→ U&Es – compare to previous eGFR → Risk factors for CKD decline: HTN, DM, smoking, infection, NSAIDs/ACEis
→ Bicarbonate – acid–base balance lost
→ Hb – normocytic anaemia Management of CKD4
→ PTH ( if bone disease & also ALP)
→ Glucose (for DM)
RISK REDUCTION of CVD: lifestyle factors are important
→ ANA, ANCA, complement 1. BP control: ACEi/ARB if proteinuria (BP<140/90 or <130/80 if diabetic)
3. USS kidney (kidneys may be small) 2. Cholesterol control: statin
Advise low salt & phosphate diet
4. Renal biopsy – if still unsure of cause 3. Comorbidity control: diabetes control
5. CXR – for pulmonary oedema 4. Stop smoking
5. Weight management
MANAGE MEDICATIONS
1. Stop drugs that worsen glomerular function / acute nephrotoxics
2. Alter dose of medications if GFR is low e.g. stop metformin if GFR <30
et al. (2019) The Kidney Failure Risk Equation for prediction of end stage renal disease in UK
5 Major,
Pleural effusion
Accumulation of fluid in pleural cavity
Types of fluid
Empyema: pus (infection) Symptoms Signs
Chylothorax: lymphatic fluid
May be asymptomatic • Expansion
Haemothorax: blood (trauma)
• SOB ± pleurisy • Stony dull percussion
Fluid: transudate or exudate
• Sx of underlying cause • Absent breath sounds
• Vocal resonance / tactile fremitus
• Tracheal deviation away if massive
Investigations
Transudate Exudate
Pathophysiology Movement of fluid from circulation → pleural space Production & secretion of fluid into pleural space
Capillary hydrostatic pressure or Capillary permeability
Capillary oncotic pressure
Causes • Congestive heart failure ( hydrostatic pressure) Inflammation: trauma, RA, sarcoid, SLE
• Renal failure ( oncotic pressure albumin) Infection: pneumonia, TB
• Liver failure ( oncotic pressure albumin) Infarction: PE, post-MI (Dressler’s)
• Hypothyroidism Malignancy: 25% of effusions
Medication: MTX, amiodarone, phenytoin
Presentation Bilateral Unilateral
Fluid Lower protein, lower LDH Higher protein, higher LDH
<25g/L protein + LDH >30g/L protein + LDH
Management Usually improve with Tx of underlying cause Pleural tap all with pneumonic illness or suspected malignancy + effusion
→ Usually do not need tapping/drainage Treat cause & drain if moderate/large
Clinical presentation
• Fever, rigors, malaise, anorexia
• Productive cough – rusty sputum / haemoptysis
• Dyspnoea
• Pleuritic chest pain
On examination
• RR, HR, temp • expansion
• O2 sats / cyanosis • coarse crackles
• GCS / delirium – if elderly • pleural rub, bronchial breathing
• Signs of consolidation • dull percussion
• vocal resonance Fig. 9.3 Right upper zone consolidation.
Postoperative care
Summary of postoperative problems
RISK FACTORS:
Patient risk factors Surgical risk factors
• Medication (steroids/ • Emergency surgery
immunosuppressants) • Longer intra-operative time
• Smoking/alcohol • Oesophageal–gastric or rectal anastomosis
• DM, obesity, malnutrition • Peritoneal contamination (by free pus or faeces)
INVESTIGATIONS:
• FBC, CRP, U&Es, LFT, clotting, VBG
• Group & save
• CT with contrast = diagnostic
MANAGEMENT:
• SEPSIS 6 (IV ABX)
• Larger leaks may need drainage or laparoscopic exploration / surgical
intervention
Intra-abdominal abscess
RISK FACTORS:
• Intra-abdominal infection (e.g. appendicitis, diverticulitis)
• Recent intra-abdominal surgery
MANAGEMENT:
• IV ABX + drainage (+ send fluid for culture)
• May need to return to theatre Surgery
Paralytic ileus
AETIOLOGY: reduced intestinal motility → very common following abdo/
pelvic surgery
RISK FACTORS:
Patient risk factors Surgical risk factors
• Increased age • Use of anti-cholinergic/opioid medication
• Electrolyte derangement (e.g. Na+, K+ • Pelvic/abdominal surgery
and Ca2+) • Extensive intra-operative intestinal
• Neurological disorders (e.g. dementia/ handling
Parkinson’s) • Peritoneal contamination (by free pus or
faeces)
CLINICAL PRESENTATION:
Ix are done to rule out
• Failure to pass faeces/flatus more serious pathologies
• Abdo distension & absent bowel sounds
• N&V
MANAGEMENT: INVESTIGATIONS:
• IV fluids & daily bloods (electrolytes) • FBC, CRP, U&Es
• Encourage mobilisation • Electrolytes (Ca2+, PO4–, Mg2+)
• Review analgesia (opiates) in • Consider imaging: AXR ± CT
conjunction with pain team (to rule out other pathology
• Consider if need to be NBM ± NG e.g. obstruction)
tube (remove stomach contents
to reduce vomiting)
Post-op haemorrhage
Primary bleed – within intra-operative period → resolved during operation &
close monitoring post-op
Reactive bleed – within 24h of operation → usually a missed vessel / slipped
ligature
More detail on haemorrhagic shock in Chapter 16: Secondary bleed – 7–10d post-op → usually erosion of a vessel 2° to infection
Critical illness
SIGNS/SYMPTOMS: tachycardia, tachypnoea, dizziness, reduced urine output
(NB: hypotension = late sign)
MANAGEMENT:
1. ABCDE → IV fluid resuscitation + direct pressure on bleeding site if visible
2. Urgent senior review → may need to return to theatre
3. Urgent blood transfusion – if moderate/severe bleeding (activate major
haemorrhage protocol if necessary)
Urinary retention
Risk factors for urinary retention:
• >50y • Opiates, PRESENTATION: MANAGEMENT:
• Spinal/epidural antimuscarinics • Reduced output • Withdraw causative agents
• Neuro comorbidity • Infection/sepsis • Suprapubic mass/pain • Catheter
• Paralytic ileus • Constipation
• Pelvic/uro surgery INVESTIGATIONS: Work-up for AKI:
• USS bladder (residual volume) • Fluid status • Urine dip
• Kidney function: eGFR, U&Es • FBC, CRP, U&Es, LFT • USS KUB
Surgery
General overview
ANY REGION
• Pancreatitis • AAA rupture
• Gallstone disease • Peptic ulcer • Mesenteric ischaemia*
▶ Biliary colic • Inferior MI • Obstruction
▶ Cholecystitis • Oesophagitis/
▶ Cholangitis GORD *Mesenteric ischaemia:
• Hepatitis consider in patients with
• Liver abscess out of proportion pain ±
metabolic acidosis
Right Left
Epigastric
• Early appendicitis hypochondriac hypochondriac
region
• Bowel obstruction region region • Splenic abscess
• Strangulated hernia • Splenic rupture
(paraumbilical/umbilical)
Fig. 11.1 This diagram should be used as a guide to the differentials of acute abdominal pain. It is important to note that any of the mentioned
pathologies can present with pain in any area of the abdomen, and thus it is important to correlate location of pain with other clinical signs and
investigations, and not to rule out differentials based on the location of pain alone.
Patterns of pain
Type of pathology
Inflammatory Obstructive Perforation Visceral
Peritonitic pain Colicky pain (waves of pain) Sudden localised then peritonitic pain Poorly localised pain (referred)
→ fever, tachycardia → vomiting, constipation → shock ( HR, RR, BP) → specific Sx e.g. jaundice
→ WCC, ESR, CRP → distension, tinkling sounds → N&V
Peritonitic pain = worse on inspiration & movement → lie still, shallow breaths, rigidity & guarding
Surgery
Things to consider:
• Nutritional and feeding status – keep NBM if surgery likely soon or vomiting
• Hydration and fluid balance – IV or oral fluid maintenance, consider catheter
• Are antibiotics indicated? – signs consistent with infection
• Investigations to guide/aid management – blood cultures, ABG, G&S, CXR, ECG
• Is blood transfusion / major haemorrhage protocol required?
• Is theatre / surgical intervention needed? – NBM, consent, book theatre slot
IMAGING INDICATIONS:
X-ray Abdo USS CT
• Obstruction • Biliary pathologies • AAA/vascular
• Toxic megacolon • Kidneys, ureter, bladder • Malignancy/mass
• Foreign body • Gynae pathologies • Complications of obstructions
• Appendix (in a female patient, no role • Appendix if >50y
in male)
Surgery
Colorectal cancer
↳ most = adenocarcinomas
→ 3rd most common cancer → Peak age: >60y
→ 2nd most common cause of → M>F
cancer deaths → 1 in 30 risk
Risk factors
Familial adenomatous polyposis (FAP):
• Polyps (UC, HNPCC, FAP) → identify & remove Polypectomy + follow-up
Auto dominant mutation in APC gene • Age (90% are aged >50 y) endoscopy (complications =
• Diet – low fibre, high fat, processed meat bleeding & perforation)
→ Hundreds of polyps
→ Presents at 35–45y (consider if <50y with • Smoking/alcohol/obesity
colorectal cancer) • IBD (UC especially)
→ Colonoscopy every 2y from 25 to 75y • Genetics (FAP & HNPCC / Lynch syndrome) • FHx
Clinical presentation
HNPCC / Lynch syndrome:
4%
Auto dominant mutation in DNA repair 3%
genes 3%
→ Cancers of colon, endometrium, ovary, Liver = common site of colorectal
stomach, bladder, brain, skin 7% cancer metastases
→ Presents >40y (consider if <50y with 5%
colorectal cancer)
→ Colonoscopy every 2y from 25 to 75y 14%
NB: non-polyposis condition (no polyps
present) 27%
Amsterdam criteria to Dx
37%
Rectum Sigmoid
Bowel cancer screening programme3:
qFIT (quantifiable faecal immunochemical Fig. 12.4 Sites of colorectal cancer.
test)
→ if >120mcg/g refer for colonoscopy to Right side Left side Rectal
remove any polyps = Late presentation • Weight loss / fatigue • Weight loss / fatigue
Every 2y from the age of 50y • Weight loss / fatigue • Change in bowel habit • Tenesmus
• IDA • Obstruction • Bright PR bleed
± Abdo pain/mass • Blood-streaked stools • DRE: palpable mass
May present as an acute emergency:
± Abdo pain/mass
• Bowel obstruction → 20% present with signs of disseminated disease e.g. liver mets = jaundice
• Bowel perforation
• Extreme pain Investigations
1. DRE 4. Colonoscopy & biopsy = gold
2. Bloods – FBC (for IDA), LFTs, U&Es standard
3. Tumour marker: CEA (not specific – 5. MRI – if rectal cancer
use for monitoring) 6. CT (chest, abdo, pelvis) – for TNM
staging
Surgery
Hartmann’s
= sigmoid colectomy with colostomy
(stoma formation)
Stoma formation:
Elective or emergency
MDT input
including stoma nurse / specialist nurse
Pathogenesis: endothelial dysfunction → inflammation → macrophages → fatty streaks Ischaemic rest pain
→ plaque → rupture → platelet adherence → thrombus
Ulceration/gangrene
Signs and symptoms
Intermittent claudication Ischaemic rest pain Peripheral neuropathy Ischaemic rest pain >2w
Often coexists alongside PAD in DM + ABPI <0.4 or TP <30mmHg
Pathology Insufficient perfusion during Constant insufficient perfusion Damaged peripheral nerves = critical limb-threatening
exercise ischaemia (CLTI)
Symptoms Cramping muscle pain Continuous, severe, burning/ Tingling/numbness ± pain can cause development of ulcers
→ on exercise (limits walking*) aching → glove & stocking distribution & gangrene ( risk if DM)
→ relieved by rest → worse at night → no relief dangling foot / cold & needs urgent Ix & Tx to
→ reproduced walking same → relieved by dangling leg out floor prevent limb loss
distance of bed → prone to wounds = infection risk
→ relieved by walking on a cold
floor Infection more likely if coexisting PAD
Signs • Absent/weak peripheral pulses • Peripheral pulses present Leriche syndrome: occluded distal
*Claudication • Cold, pale, hairless legs • No pallor with Buerger’s aorta, iliac & femoro-popliteal
distance vessels
• Buerger’s angle <20° (angle leg raised
→ bilateral buttock/thigh pain
before pallor) ± erectile dysfunction
Management10
ABPI Interpretation9 Action
MEDICAL Action is based on severity of symptoms
>1.3 Calcification (diabetes) TBPI (toe BPI)
• Lifestyle: stop smoking, weight loss, exercise programmes (weekly for 3m)
1–1.3 Normal No action
• Optimise comorbidities: HTN, DM, cholesterol (high dose statin)
• Antiplatelets: 75mg clopidogrel (or 2.5mg rivaroxaban BD + 75mg aspirin) 0.4–0.9 Mild–moderate PAD Routine
• Vasoactive drugs: consider use in claudicants e.g. naftidrofuryl or cilostazol (intermittent referral
claudication)
9 Cronenwett JL & Johnston KW (2014) Rutherford's Vascular Surgery. 8th edition. Elsevier Health <0.4 Severe PAD (rest pain)
Urgent
Sciences
10 European Society for Vascular Surgery (2019) Clinical practice guideline on management of chronic <0.3 Impending gangrene referral
limb-threatening ischemia
Surgery
SURGICAL → consider in more severe cases or where medical treatment has failed
• Percutaneous transluminal angioplasty (PTA) or stenting
Common sites of atherosclerosis
• Surgical reconstruction (bypass graft)
• Coronary arteries • Amputation = last resort
• Major branches of the aortic arch
• Visceral branches of abdo aorta Chronic mesenteric vascular occlusive disease
• Terminal abdominal aorta + branches
→ atherosclerosis of SMA, coeliac trunk & IMA*, causing inadequate perfusion for
*Good collateral blood supply so symptoms only digestion → ‘gut claudication’
likely to occur if ≥2 vessels affected
CLINICAL PRESENTATION: (at least 3m duration)
• Postprandial epigastric pain: 10min to 3h after eating
Risk factors for chronic mesenteric vascular • Gross weight loss & fear of eating (but appetite unaffected)
occlusive disease: as for all arterial disease • Non-specific GI symptoms: altered bowel habits, N&V
(+ typically females >60y) • ± other vascular comorbidities e.g. HTN, DM, smoking etc.
11 European Society for Vascular Surgery (2017) Clinical practice guideline on management of the
Clinical presentation
Urinary bladder
1. Lower urinary tract symptoms (LUTS) rapid onset Pubic bone Ureter
2. Acute urinary retention: suprapubic pain, palpable bladder, anuria Ductus Seminal
vesicle
deferens
3. Chronic urinary retention: LUTS, renal impairment, palpable bladder, Prostate
Urethra gland
overflow incontinence, large residual urine volume
Penis
Rectum
Epididymis
Voiding symptoms Storage symptoms Anus
Testis
Hesitancy Frequency
Poor flow Urgency ± urge incontinence ‘FUN’ Fig. 15.5 Male genitourinary anatomy.
Post-void dribbling Nocturia
Dysuria (bedwetting / overflow Incontinence)
(sensation of incomplete emptying) IPSS: score/questionnaire to determine how
much symptoms impact daily life
Present in obstruction Present if bladder dysfunction
(can be 2° to chronic obstruction)
CLINICAL PRESENTATION:
• Voiding symptoms ± secondary storage symptoms
• ± Haematuria
Chronic urinary retention
• Enlarged, smooth prostate on DRE
Chronic obstruction can lead to chronic urinary • Acute retention (sometimes occurs = rapid & painful)
retention → gradual stretching of bladder over
years (painless) INVESTIGATIONS:
• Symptoms: asymptomatic or LUTS, palpable 1. History & examination: IPSS score & remember DRE
bladder, overflow incontinence, large residual 2. Urinalysis: dip & MCS
volume of urine 3. Uroflowmetry: <10ml/sec suggests obstruction
• Complications: UTIs, calculi, high pressure 4. Bloods: including PSA
chronic retention (HPCR) → renal impairment 5. Transrectal USS + biopsy: definitive diagnosis
& hydronephrosis
MANAGEMENT8: depends on symptom severity
8 NICE (2010, updated 2015) Lower urinary tract symptoms in men [CG97]
Surgery
Electrolyte abnormalities
Hyperglycaemia (DKA & HHS)
DIAGNOSIS:
DKA HHS
1. Hyperglycaemia: random BG >11mmol/L 1. Profound hyperglycaemia: random BG
2. Ketosis: capillary ketones >3mmol/L or >30mmol/L
urinary ketones ++ 2. No ketosis & pH >7.3
3. Acidosis: HCO3− <15 or pH <7.35 3. High osmolality: >320mosmol/kg
*Avoid rapid
IV fluids*
rehydration as risk
0.9% saline (1L over 1h)
cerebral oedema
Tests:
VBG for pH, HCO3−, glucose, ketones
U&Es, FBC, CRP, CXR, ECG
Monitor hourly:
Identify & treat underlying cause • Blood glucose
e.g. ABX if septic • Blood ketones
• VBG (pH, HCO3−, K+)
Also monitor:
Once stable • Urine output
• switch to SC insulin • U&Es (K+, Cr, urea)
• encourage regular feeding & fluids • Neurological state
Fig. 17.2 DKA management in adults.
1 Diabetes UK (2012) The management of hyperosmolar hyperglycaemic state (HHS) in adults with
diabetes
2 Diabetes UK (2021) The management of diabetic ketoacidosis in adults
Critical illness
Hypoglycaemia3
CAUSES:
• Reduced oral intake Hypoglycaemia = blood glucose <4mmol/L
• Intense exercise
• Binge drinking
• Taking too much insulin (if diabetic)
SYMPTOMS:
• Irritable, anxious, confused
• Hungry or nauseous
• Shaky, dizzy, light-headed
• Seizures if severe
MANAGEMENT:
1. Oral rapid-acting glucose or IV glucose 100ml 20% / IM glucagon 1mg
2. Long-acting carbohydrate e.g. toast (once CBG >4mmol/L)
3. Look for cause (document, monitor and get specialist review if needed)
Hyperkalaemia
CAUSES:
• CKD / renal failure
• Drugs (ACEis/ARBs, NSAIDs, spironolactone, potassium supplements)
• Burns / trauma / tissue injuries
• Hormonal disorders e.g. Addison’s Hyperkalaemia = K+ >5.2mmol/L
Severe hyperkalaemia = K+ >6mmol/L
SYMPTOMS:
• Chest pain / palpitations
• Dizziness/weakness
• Abdominal pain / vomiting
INVESTIGATIONS:
• U&Es
• ECG – tented T waves, flattened P wave, shortened QT interval
MANAGEMENT:
1. 10ml 10% calcium gluconate
2. IV insulin + 25g glucose
3. Salbutamol nebs
4. Treat cause
Cervical myelopathy
CERVICAL CANAL STENOSIS → cord compression = more serious than
cervical radiculopathy
Causes:
• Age-related degeneration: osteophyte formation & ligament hypertrophy
• Disc bulging/herniation: consider in younger patients
Affects middle-aged/elderly
Symptoms: gradual onset so late presentation & Dx
• Gait abnormalities: spastic & ataxic
• Loss of fine motor skills → difficulty fastening buttons, writing etc.
• Later = tingling in fingers (may be misdiagnosed as carpal tunnel syndrome)
± sphincter dysfunction
Hoffman’s sign: flick middle finger & watch for On examination:
reflexive movement of index/thumb • Gait abnormalities: spastic & ataxic
→ positive in UMN pathology e.g. spinal cord • Wasting on shoulder girdle muscles
compression • UMN signs: spasticity, clonus, +ve Hoffman’s/Babinski, hyperreflexia,
hypertonia
Investigations: X-ray & MRI
Management:
Surgical intervention: laminectomy → recommended as progressive
deterioration
Lumbar radiculopathies
Lower limb dermatomes LUMBAR DISC PROLAPSE = common in those aged 25–55y
L4 Inner shin, below knee Pathology:
L5 Buttock, lateral calf, big toe • With age = increased risk of prolapse through defect in surrounding annulus
fibrosus
S1 Post. thigh & calf, little toe • Results in compression of nerve roots
Symptoms: often onset during lifting/
Prolapsed nucleus
bending/twisting Vertebra presses on nerve root
Usually posterolateral herniation of disc, • Stabbing lower back pain
therefore compresses nerve root below → radiating down the leg/buttock
i.e. herniated L5/S1 disc will compress S1 • Numbness/tingling (in one leg)
nerve root On examination:
Nerve root
• Pain reproduced with straight leg
raise Nucleus
Sciatica = pain along path of sciatic nerve • Motor signs: modest lower muscle pulposus
(radiates down to toe) due to disc prolapse, weakness (usually unilateral)
Annulus fibrosus
stenosis or osteophytes affecting nerve • Sensory signs: reduced pin-prick
Fig. 18.9 Anatomy of disc prolapse.
roots L4–S1 sensation discrimination
(one dermatome)
• LMN signs: hyporeflexia, hypotonia
Discs are named after vertebra above & below • May be scoliosis due to paravertebral muscle spasm
e.g. L4/5 or L3/4 Diagnosis: usually clinical
• Neurological examination: myotomes, dermatomes, reflexes
• MRI if no improvement / considering surgery
Management: 90% self-limiting in 6–12w
Complications of surgery :
Nerve damage, CSF leak, infection, haemorrhage, 1. Conservative: rest, physiotherapy, analgesia (NSAIDs or neuropathic – TCAs)
back pain 2. Surgical: if no improvement in 6w
• Nerve root block (under fluoroscopic guidance)
• Microdiscectomy (remove piece of prolapsed disc)
Musculoskeletal disease
Musculoskeletal malignancy
Soft tissue swellings
*Urgent referral if red flags:
1. 2ww for USS Benign Malignant
2. If USS worrying/unclear: 2ww cancer • <5cm or slow-growing • >5cm or rapid increase in size*
pathway (MRI & biopsy) • Painless • Painful*
• Superficial to fascia • Penetrates fascia (deep within muscle)*
If no worrying features:
• Well-circumscribed • Irregular border / not contained
observe or biopsy + histology
• Homogeneous appearance • Heterogeneous radiological appearance
e.g. lipoma, leiomyoma, schwannoma e.g. sarcoma
Multiple myeloma
→ malignancy of plasma cells of bone marrow: proliferation of one type of
plasma cell producing one type of Ig
SYMPTOMS:
• Bone pain (commonly backache)
• Fractures of long bones & vertebral collapse Average age: >70y
• Hypercalcaemia (due to increased osteolytic activity)
• Anaemia, neutropenia, thrombocytopenia RF: Afro-Caribbean
• ± Renal impairment & recurrent infections
INVESTIGATIONS:
• FBC: anaemia, WCC, ESR/CRP
• U&Es, LFTs: deranged renal function in 20% Poor prognosis:
• Bone profile: hypercalcaemia 6y median survival
• Plasma electrophoresis: monoclonal Igs
• Urine microscopy: Bence Jones proteins (monoclonal light chains)
• X-rays: punched-out osteolytic lesions (‘pepper-pot’)
• Bone scintigraphy: may have cold spots
• Bone marrow biopsy: >10% clonal plasma cells
MANAGEMENT:
• Supportive for complications e.g. anaemia, renal failure
• Localised disease: radiotherapy
• Widespread disease: chemotherapy
Musculoskeletal disease
ON EXAMINATION:
• Bony tenderness
• Swelling Differentials:
• Reduced ROM in joints • Multiple myeloma
• Lymphadenopathy NB: if no Hx of • Lymphoma
• Anaemia cancer, consider • Bone infection
primary bone tumour
• Neurological deficit
MANAGEMENT:
1. Find primary source: X-ray, CT, MRI, bone scan
2. Supportive
• Pain relief
• Bone protection: splints/bisphosphonates (assess fracture risk)
3. Chemo/radiotherapy
4. Surgery:
• Stabilisation if risk of fracture in long bones / vertebrae
• Arthroplasty if joint involvement